Trevena, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Pipeline
    • Overview
    • TRV250
    • TRV734
    • TRV045
    • TRV027
  • Products
    • OLINVYK™ (oliceridine) injection
  • Medical Affairs
    • Investigator-Initiated Trials
    • Contact Medical Information
  • Publications
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financial Info
    • Stock Info
    • Resources
    • Governance
  • Careers
  • Contact
    • Contact Medical Information
    • Whistleblower Hotline

Press Releases

Investors

Investors

  • Overview
  • Press Releases
  • Events & Presentations
    • Presentations
    • IR Calendar
  • Financial Info
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Stock Info
    • Quote
    • Analyst Coverage
  • Resources
    • Email Alerts
    • Contacts
    • FAQ
  • Governance
    • Overview
    • Management Team
    • Board of Directors
    • Governance Documents

Trevena Announces Pricing of $50 Million Public Offering of Common Stock

Aug 12, 2020 9:27am EDT

Trevena Announces Proposed Public Offering of Common Stock

Aug 11, 2020 4:01pm EDT

Trevena Announces FDA Approval of OLINVYK™ (oliceridine) injection

Aug 10, 2020 6:30am EDT

Trevena Announces Advancement of Oliceridine Clinical Development in China by Jiangsu Nhwa Pharmaceutical Co.

Jun 03, 2020 8:02am EDT

Trevena Announces Collaboration with Imperial College London to Evaluate TRV027 in COVID-19 Patients

Jun 02, 2020 7:00am EDT

Trevena Reports First Quarter 2020 Results

May 07, 2020 7:00am EDT

Trevena to Release First Quarter 2020 Financial Results on May 7, 2020

May 01, 2020 7:00am EDT

Trevena Announces Publication of Comprehensive Review of Oliceridine Data

Apr 23, 2020 7:00am EDT

Trevena Reports Fourth Quarter and Full Year 2019 Results

Mar 12, 2020 7:01am EDT

Trevena to Report Fourth Quarter and Full Year 2019 Results on March 12, 2020

Mar 05, 2020 5:00pm EST
RSS
  • Prev
    • 1...
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • ...30
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
    © 2022 Trevena, Inc. All Rights Reserved.
    Privacy Policy Terms of Use Disclaimer Sitemap